Assertio Holdings | DEPO - Net Income

Stock Price
19.39
Daily Change
-0.14 -0.72%
Monthly
64.74%
Yearly
86.88%
Q1 Forecast
18.01

Assertio Holdings reported $-2.92M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
ANI Pharmaceuticals USD 32.35M 6.08M Dec/2025
Assertio Holdings USD -2.92M 753K Sep/2024
Aurora Cannabis CAD 1.82M 53.29M Dec/2025
Cara Therapeutics USD -4.91M 2.77M Mar/2025
Daiichi Sankyo JPY 86.63B 41.32B Dec/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
J&J USD 5.12B 36M Dec/2025
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Merck USD 2.96B 2.82B Dec/2025
Nektar Therapeutics USD -37.06M 15.31M Sep/2024
Omeros USD -32.23M 23.81M Sep/2024
Pfizer USD -1.65B 5.19B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025